710-1070

completed

Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. · Phase II
710 (USA) · Dr. Silva
consented 2012-09-08

AEs

Serious

Dropout signal

–

Adverse events

mild assessed

Mild ERYTHEMA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-12-12 (study day 96.0); relationship: PROBABLE

severe assessed

Severe GASTROINTESTINAL HAEMORRHAGE — outcome: RECOVERED/RESOLVED; onset 2013-02-05 (study day 151.0); relationship: NONE; serious criteria: hospitalization

severe assessed

Severe HIP FRACTURE — outcome: RECOVERED/RESOLVED; onset 2013-01-22 (study day 137.0); relationship: NONE; serious criteria: hospitalization

mild assessed

Mild PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-12-12 (study day 96.0); relationship: PROBABLE

mild assessed

Mild RASH — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-12-12 (study day 96.0); relationship: PROBABLE

mild assessed

Mild SUPRAVENTRICULAR EXTRASYSTOLES — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-10-06 (study day 29.0); relationship: POSSIBLE

Data queries

No data queries.